9amHealth, founded in 2021, provides virtual cardiometabolic care in the United States, operating in 47 states and the District of Columbia. The company treats obesity, diabetes, and heart conditions as interconnected issues, offering a whole-body approach rather than addressing each condition in isolation.
Care is delivered through multidisciplinary teams that include obesity specialists, pharmacists, dietitians, and behavioral health experts. These teams develop personalized treatment plans that may incorporate prescription medication delivery, at-home lab tests, connected devices, and unlimited specialist access via a mobile app. Reported clinical outcomes include an average weight reduction of 17.6% with GLP-1 medications over 12 months and an A1c reduction of 2.8%.
The company was founded on the principle that managing chronic conditions should be affordable, accessible, and kind. Many team members live with diabetes or have close family members who do, contributing to a patient-centric culture rooted in personal connection to the mission.
